Forecast

There is no analyst data available for this company.

News Go to news feed

NRS Healthcare faces insolvency after cyberattack and financial troubles

NRS Healthcare, a leading British manufacturer of medical equipment, is on the verge of forced liquidation following a cyberattack in March 2024 and additional financial pressures. Despite a swift operational recovery, the company was unable to secure new investors and is expected to become insolvent soon. The impending insolvency could lead to significant supply shortages in the UK healthcare system. » More on golem.de

Historical dividends Dividends

All dividend metrics All metrics

In 2021, Norway Royal Salmon has already paid €0.0992 in dividends. The last payout was in June 2021.

Financials

In the last year, Norway Royal Salmon had revenue of €578.51M and net profit of €69.15M

(EUR)	2021	YoY
Revenue	578.51M	18.88%
Gross profit	120.68M	115.78%
Net profit	69.15M	873.97%
EBITDA	94.36M	423.80%

Fundamentals

Metric	Value
Market capitalization	€0
52-week high/low	€24.39 - €11.23
Dividends	No
Beta	0.16
P/E ratio	9.48
PEG ratio	-0.25
P/B ratio	1.79
P/S ratio	0.00

Company profile

Norway Royal Salmon ASA produziert, erntet, verkauft und vermarktet Smolt und Lachsprodukte in Norwegen. Das Unternehmen bietet frischen und gefrorenen Lachsfisch, Rundfisch, Filet, Portionen sowie geräucherte und marinierte Produkte an. Außerdem exportiert es seine Produkte in 48 Länder. Norway Royal Salmon ASA wurde 1992 gegründet und hat seinen Hauptsitz in Trondheim, Norwegen. Norway Royal Salmon AS arbeitet als Tochtergesellschaft von NTS ASA.